GlassScriptPhysician profile
Alexander G Bien
NPI 1881734614
$15,070.56
in general payments reported to CMS, 2019-2025
11 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $39.78 · 2021: $343 · 2022: $567 · 2023: $924 · 2024: $12K · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,640 · Food and Beverage: $2,902 · Travel and Lodging: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,640.00 |
| Food and Beverage | $2,902.16 |
| Travel and Lodging | $1,835.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,303.40 | 2023-2024 | Midas Rex, Stealthstation S8 Platform, N/A |
| Med-El Corporation | $1,500.41 | 2019-2025 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit |
| Advanced Bionics, LLC | $580.06 | 2019-2022 | |
| Grace Medical, INC. | $556.18 | 2023-2024 | |
| Cochlear Americas | $393.32 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Axogen | $309.60 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Stryker Corporation | $208.47 | 2019-2025 | Nico Myriad Spectra |
| Glaxosmithkline, LLC. | $124.77 | 2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $53.47 | 2019 | |
| Springworks Therapeutics, INC. | $21.73 | 2025 | Gomekli |
| Smith+Nephew, INC. | $19.15 | 2025 | Halo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Bien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.